High Tech Pharm Balance Sheet Health
Financial Health criteria checks 5/6
High Tech Pharm has a total shareholder equity of ₩109.5B and total debt of ₩16.7B, which brings its debt-to-equity ratio to 15.3%. Its total assets and total liabilities are ₩147.1B and ₩37.5B respectively. High Tech Pharm's EBIT is ₩14.3B making its interest coverage ratio 16.4. It has cash and short-term investments of ₩14.8B.
Key information
15.3%
Debt to equity ratio
₩16.73b
Debt
| Interest coverage ratio | 16.4x |
| Cash | ₩14.79b |
| Equity | ₩109.54b |
| Total liabilities | ₩37.54b |
| Total assets | ₩147.08b |
Recent financial health updates
Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23
We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Recent updates
There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?
Jan 19What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?
Dec 15Financial Position Analysis
Short Term Liabilities: A106190's short term assets (₩69.5B) exceed its short term liabilities (₩32.2B).
Long Term Liabilities: A106190's short term assets (₩69.5B) exceed its long term liabilities (₩5.3B).
Debt to Equity History and Analysis
Debt Level: A106190's net debt to equity ratio (1.8%) is considered satisfactory.
Reducing Debt: A106190's debt to equity ratio has increased from 7% to 15.3% over the past 5 years.
Debt Coverage: A106190's debt is well covered by operating cash flow (81.7%).
Interest Coverage: A106190's interest payments on its debt are well covered by EBIT (16.4x coverage).